| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/30/2002 | EP1175217A2 (s)-benzoquinolizine carboxylic acids and their use as antibacterial agents |
| 01/30/2002 | EP1175216A2 Antimalarian agents for the treatment of asthma |
| 01/30/2002 | EP1175215A2 Use of osanetant in the production of medicaments used to treat mood disorders |
| 01/30/2002 | EP1175214A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 01/30/2002 | EP1175213A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/30/2002 | EP1175212A1 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity |
| 01/30/2002 | EP1175211A2 Anticonvulsant derivatives useful in treating cocaine dependency |
| 01/30/2002 | EP1175210A1 Increasing cerebral bioavailability of drugs |
| 01/30/2002 | EP1175209A2 Use of antiepileptics for treating respiratory disorders, in particular asthmatic disorders |
| 01/30/2002 | EP1175208A1 Composition for preventing or treating dementia comprising a hydroxycinnamic acid derivative or an extract of a plant of genus angelicae containing same |
| 01/30/2002 | EP1175206A1 Pharmaceutical compositions comprising apocodeine and/or its derivatives |
| 01/30/2002 | EP1175205A2 Inhibitors of crystallization in a solid dispersion |
| 01/30/2002 | EP1175204A1 Aerosol formulations and devices for increasing libido in women via acute testosterone administration |
| 01/30/2002 | EP1175203A1 Folic acid supplement |
| 01/30/2002 | EP1175157A1 Low molecular weight polymannuronate |
| 01/30/2002 | EP1175155A1 Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof |
| 01/30/2002 | EP1175154A1 Method for manufacturing rumen bypass feed supplement |
| 01/30/2002 | EP1175149A1 Disinfecting composition based on h2o2, acids and metal ions |
| 01/30/2002 | EP1173153A4 Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants |
| 01/30/2002 | EP1071429B1 Map kinase inhibitors in the treatment of disorders caused by tnf-alpha induced lipolysis |
| 01/30/2002 | EP1045897B1 Enzyme catalyzed therapeutic agents |
| 01/30/2002 | EP1045681A4 METHOD AND COMPOSITIONS FOR $i(IN SITU) FORMATION OF PROTECTIVE AND/OR MEDICATED FILMS ON BODY TISSUE |
| 01/30/2002 | EP1021442B1 8-azabicyclo 3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors |
| 01/30/2002 | EP1019395B1 Farnesyl transferase inhibiting 2-quinolone derivatives |
| 01/30/2002 | EP0991409B1 Controlled release pharmaceutical compositions containing tiagabine |
| 01/30/2002 | EP0956009B1 Treatment of neurodegenerative conditions with nimesulide |
| 01/30/2002 | EP0942920B1 Steroid esters, method for the manufacture thereof and their pharmaceutical use |
| 01/30/2002 | EP0937044B1 Cftr channel activator compounds and pharmaceutical compositions containing same |
| 01/30/2002 | EP0934267B1 Alpha-amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors |
| 01/30/2002 | EP0904284B1 6-substituted amino-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives as cysteine protease inhibitors |
| 01/30/2002 | EP0900225B1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 01/30/2002 | EP0896521A4 Composition, barrier film, and method for preventing contact dermatitis |
| 01/30/2002 | EP0891187B1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
| 01/30/2002 | EP0888373A4 Smooth muscle cell lim protein |
| 01/30/2002 | EP0868183B1 Injectable quinolone formulations |
| 01/30/2002 | EP0866791B1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
| 01/30/2002 | EP0863876B1 Quinoline derivatives containing a diol as leukotriene antagonists |
| 01/30/2002 | EP0836602B1 Fungicidal pyrimidinones |
| 01/30/2002 | EP0832198A4 Oxygen activatable formulations for disinfection or sterilization |
| 01/30/2002 | EP0819136B1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same |
| 01/30/2002 | EP0814771B1 Improvements in or relating to organic compositions |
| 01/30/2002 | EP0777480A4 Optic nerve health |
| 01/30/2002 | EP0744946B1 Compositions containing micronized nebivolol |
| 01/30/2002 | EP0724571B1 Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides |
| 01/30/2002 | EP0707580B1 Magnesium omeprazole |
| 01/30/2002 | EP0668913B1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 01/30/2002 | EP0564502B1 Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
| 01/30/2002 | CN1333873A HIV-specfic T-cell induction |
| 01/30/2002 | CN1333830A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 01/30/2002 | CN1333828A Compositions and methods for increasing bone mineralization |
| 01/30/2002 | CN1333820A Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 01/30/2002 | CN1333784A Benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 01/30/2002 | CN1333783A Macrolide intermediates in the preparation of clarithromycin |
| 01/30/2002 | CN1333782A New derivatives of erythromycin, process for making them and use as medicaments |
| 01/30/2002 | CN1333781A Benzylglycosylamides as inhibitors of smooth muscle cell proliferation |
| 01/30/2002 | CN1333780A Benzylglycosylmmides as inhibitors of smooth muscle cell proliferation |
| 01/30/2002 | CN1333779A Benzyllactobionamides as inhibitors of smooth muscle cell proliferation |
| 01/30/2002 | CN1333778A Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation |
| 01/30/2002 | CN1333776A Imidazo [4,5-b] pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum |
| 01/30/2002 | CN1333775A Process and products of purification of anhydrosugar alcohol |
| 01/30/2002 | CN1333774A Substituted benzofuranodindoles and indenoindoles as novel potassium channel openers |
| 01/30/2002 | CN1333773A Process for preparing N6-substituted deaza-adenosine derivatives |
| 01/30/2002 | CN1333772A Imidazo (4,5-c)-pyridine-4-on-derivatives |
| 01/30/2002 | CN1333771A Benzoxazole derivatives and druges containing the same as the active ingredient |
| 01/30/2002 | CN1333770A Novel dicyclic compound |
| 01/30/2002 | CN1333769A Thiourea inhibitors of herps viruses |
| 01/30/2002 | CN1333767A Aromatic heterocyclic compounds as antiinflammatory agent |
| 01/30/2002 | CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors |
| 01/30/2002 | CN1333765A Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 01/30/2002 | CN1333758A Substituted bicyclic derivatives useful as anticancer agents |
| 01/30/2002 | CN1333757A Quinazoline derivatives as medicaments |
| 01/30/2002 | CN1333756A Crystalline bis [(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl)amino] pyrimidin-5-yl](3R,5S-3,5-dihydroxyhept-6-enoic acid] calcium salt |
| 01/30/2002 | CN1333755A Benzimidazole compounds that are vitronectin receptor antagonists |
| 01/30/2002 | CN1333754A Benzoheterocycles and their use as MEK inhibitors |
| 01/30/2002 | CN1333753A Quinolinecarboxamides as antiviral agents |
| 01/30/2002 | CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 01/30/2002 | CN1333747A ((Aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy |
| 01/30/2002 | CN1333746A Molecular scaffolds acting as templates comprising carbamate linkages |
| 01/30/2002 | CN1333698A Combination chemotherapy |
| 01/30/2002 | CN1333695A Blood pool agents for nulcear magnetic resonance diagnostics |
| 01/30/2002 | CN1333694A Stable amorphous amifostine compositions and methods for the preparation and use of same |
| 01/30/2002 | CN1333686A Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions |
| 01/30/2002 | CN1333685A Utilisation of I compound for the prophylaxis and therapy of cerebral ischaemia |
| 01/30/2002 | CN1333684A Use of 5HT3 receptor antagouists for the treatment of chronic fatigue syndrome |
| 01/30/2002 | CN1333683A Pharmaceutical composition for modified release insulin sensitiser |
| 01/30/2002 | CN1333682A Storable active substance concentrate with formoterol |
| 01/30/2002 | CN1333681A Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood tribly cerides |
| 01/30/2002 | CN1333680A Oral formulation for gastrointestinal drug delivery |
| 01/30/2002 | CN1333677A Composition set and kit for use in intraocular surgery |
| 01/30/2002 | CN1333675A Cream cleanser with high levels of emollients and glycerin |
| 01/30/2002 | CN1333651A Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method |
| 01/30/2002 | CN1333339A Polytype gene of MXA protein and application thereof |
| 01/30/2002 | CN1333338A Papilloma pseudovirus and process for preparing same |
| 01/30/2002 | CN1333212A pregnanedione compound, preparation method and use |
| 01/30/2002 | CN1333210A Diphosphonic acid derivant and preparation process and application thereof |
| 01/30/2002 | CN1333207A Sparfloxacin salt and synthesis method and use thereof |
| 01/30/2002 | CN1333206A Sulfuryl diphenyl indole compound and preparation process and use in medicine |
| 01/30/2002 | CN1333054A Medicine for relieving cough and asthma |
| 01/30/2002 | CN1333036A Hair-growing powder medicine and preparation process thereof |
| 01/30/2002 | CN1333020A Biochemical material composition for preventing and treating disease caused by smooth muscle cell contraction in human organ |